Get the Stockscreener App
157.69
1.57%
2.56
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $157.69, with a volume of 196.76K.
It is up +1.57% in the last 24 hours and down -4.61% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$155.13
Open:
$155.81
24h Volume:
196.76K
Relative Volume:
0.33
Market Cap:
$8.54B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-17.10
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-1.54%
1M Performance:
-4.61%
6M Performance:
-9.00%
1Y Performance:
+46.65%
1-Day Range:
$154.54
$157.79
1-Week Range:
$153.36
$161.09
52-Week Range:
$101.61
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
157.56 | 8.77B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
124.81 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.67 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.83 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.19 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.15 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Corporation Stock Analysis and ForecastExceptional profit velocity - jammulinksnews.com
Is Masimo Corporation a good long term investmentRemarkable growth - jammulinksnews.com
What analysts say about Masimo Corporation stockFree Popular Stock Recommendations - Jammu Links News
Lobbying Update: $110,000 of MASIMO CORPORATION lobbying was just disclosed - Quiver Quantitative
Masimo Corp. Settles Investor Suit Over Revenue Disclosures - Law360
Samsung to buy US health tech firm Xealth in digital health push - KED Global
Masimo Criticizes Bid To DQ Quinn Emanuel In Payout Suit - Law360
Joe Kiani Appointed CEO of Santa Monica Media Company - Orange County Business Journal
Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years - Benzinga
Masimo Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation - MarketScreener
Apple wants U.S. appeals court to overturn decision that forced it to remove blood-oxygen reading tech from the Apple Watch - MacTech.com
Europe Respiratory Care Devices Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Koninklijke Philips, GE, Masimo, ResMedInc, BD and Co, Chart Industries, Getinge - Yahoo Finance
5 Federal Circuit Clashes To Watch In July - Law360
Piper Sandler reiterates Masimo stock rating, cites new CEO impact By Investing.com - Investing.com South Africa
Masimo Fails to Disqualify Law Firm on Ousted Founder’s Team (1) - Bloomberg Law News
This Week in Chancery Court: Atlas Energy Solutions, Masimo (1) - Bloomberg Law News
Multiple Executive Changes Announced by Masimo; COO Muhsin to Resign July 1 - Strata-gee.com
Masimo COO to Resign - Orange County Business Journal
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties - GlobeNewswire Inc.
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia - marketscreener.com
Rhumbline Advisers Cuts Stock Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
New Masimo CEO Katie Szyman Reveals Personal Ties to Device Maker - Orange County Business Journal
Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand - Law360
Masimo Corp (MASI) Stock Price Up 3.31% on Jun 6 - GuruFocus
Transcript : Masimo Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - MarketScreener
Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today - Benzinga
Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI) - Yahoo Finance
BTIG maintains Buy on Masimo stock with $193 price target - Investing.com India
BTIG maintains Buy on Masimo stock with $193 price target By Investing.com - Investing.com Canada
Masimo Founder Slaps Board With Lawsuit Over His Ouster - Law360
Is the Market Bullish or Bearish on Masimo? - Benzinga
Masimo Updates SEC on Its Progress Recovering From Recent Cyberattack - Strata-gee.com
Masimo (MASI) Reaffirms 2025 Outlook Despite Cybersecurity Incident - GuruFocus
Masimo Corporation: Will The Sound United Divestiture & Financial Realignment Efforts Meet Their Ultimate Goal? - Smartkarma
Masimo Corp (MASI) Trading 3.93% Higher on May 27 - GuruFocus
Masimo (MASI) Reassures Investors on Financial Outlook | MASI Stock News - GuruFocus
Masimo rallies after saying cyber attack won’t hurt 2025 sales - TipRanks
Masimo Corp maintains outlook despite cyber incident By Investing.com - Investing.com South Africa
Masimo Corp maintains outlook despite cyber incident - Investing.com
Masimo Leadership Takes Stage at Jefferies Healthcare Conference: Key Investor Presentation Coming June 4 - Stock Titan
Masimo says cyberattack will not prevent it from fulfilling orders - Cybersecurity Dive
MASI Q1 Earnings Call: Revenue Tops Expectations, Focus Shifts to Healthcare Core Amid Tariff Headwinds - Yahoo Finance
Midday Stock Roundup: RxSight Up 13% on Wells Fargo Upgrade - Orange County Business Journal
Masimo Tells SEC It Was the Victim of a Cyberattack - Strata-gee.com
Masimo Sells Sound United to Harman; Excited? Temper Your Enthusiasm - Strata-gee.com
Transcript : Masimo Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04 - marketscreener.com
Masimo at BofA Healthcare Conference: Strategic Realignment for Growth - Investing.com
Recent Investment Analysts’ Ratings Changes for Masimo (MASI) - Defense World
Do You Believe in the Growth Potential of Masimo Corporation (MASI)? - MSN
INVESTOR ALERT: Potential Recovery for Masimo Corporation (MASI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
INVESTOR ALERT: Levi & Korsinsky Notifies Masimo Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineMASI - ACCESS Newswire
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):